The New Normal (Normal 1.0) changed everything, including healthcare. The pharmaceutical sector, which is heavily reliant on relationships with healthcare professionals and patients, saw everything coming to a sudden halt.
The medical industry has come a long way from the days of pandemic-related restrictions like working from home, social isolation, and almost zero engagement opportunities. The industry prepared its resurgence by activating its Business Continuity Plans (BCP) through digital solutions and channels of engagement.
The Newer Normal (Normal 2.0) will always be in a flux - we will move back and forth between lockdown and reopening of cities and states. How fast one is able to respond to these aberrations will emerge as a critical success factor.